Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
223.43
+4.41 (+2.01%)
Official Closing Price
Updated: 7:00 PM EST, Feb 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,067,103
Open
218.75
Bid (Size)
223.20 (300)
Ask (Size)
225.00 (100)
Prev. Close
219.02
Today's Range
218.50 - 225.82
52wk Range
164.39 - 244.81
Shares Outstanding
N/A
Dividend Yield
3.10%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
February 06, 2026
The life sciences sector has entered 2026 in the midst of a historic transformation, as deal volume and value surged by a staggering 82% over the past year. This "Great Rebound," fueled by a...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
AbbVie’s Prognosis: The February Dip Looks Like a Buy Signal
↗
February 05, 2026
Via
MarketBeat
Performance
YTD
-2.6%
-2.6%
1 Month
-4.3%
-4.3%
3 Month
+1.9%
+1.9%
6 Month
+12.8%
+12.8%
1 Year
+15.8%
+15.8%
More News
Read More
ABBV Q4 Deep Dive: Immunology and Neuroscience Growth Offset Aesthetics Softness and Pricing Headwinds
February 05, 2026
Via
StockStory
AbbVie Inc. (NYSE:ABBV) Raises 2026 Outlook Despite Q4 Revenue Miss
↗
February 04, 2026
Via
Chartmill
AbbVie (ABBV) Q4 2025 Earnings Call Transcript
↗
February 04, 2026
Via
The Motley Fool
Topics
Earnings
Gapping S&P500 stocks in Wednesday's session
↗
February 04, 2026
Via
Chartmill
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
↗
February 04, 2026
Via
Chartmill
AbbVie’s (NYSE:ABBV) Q4 CY2025: Beats On Revenue
February 04, 2026
Via
StockStory
2 Healthcare Dividend Stocks That are Just What the Doctor Ordered
↗
February 03, 2026
Via
The Motley Fool
Topics
Intellectual Property
AbbVie (ABBV) Q4 Earnings: What To Expect
February 02, 2026
Via
StockStory
The Sound of Silence: Revolution Medicines Plummets 17% as M&A Hopes Evaporate
February 02, 2026
Via
MarketMinute
Topics
ETFs
Government
Initial Public Offering
Where Will AbbVie Be in 5 Years?
↗
February 02, 2026
Via
The Motley Fool
Topics
Intellectual Property
2 No-Brainer Dividend Stocks to Buy Hand Over Fist
↗
February 01, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
Better Long-Term Buy: This Emerging Player or the Industry Leader?
↗
January 30, 2026
Via
The Motley Fool
Topics
Intellectual Property
Q3 Earnings Highs And Lows: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks
January 28, 2026
Via
StockStory
Topics
Artificial Intelligence
Why AbbVie Stock Trounced the Market in 2025
↗
January 28, 2026
Via
The Motley Fool
Topics
Intellectual Property
Eli Lilly Reinforces Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences
January 27, 2026
Via
MarketMinute
Why Revolution Medicines Stock Plummeted by Almost 17% Today
↗
January 26, 2026
Via
The Motley Fool
The $6 Billion Disconnect: Why Revolution Medicines (RVMD) Plunged 20% After Merck Talks Collapsed
January 26, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
The Best Dividend Stocks to Buy and Hold Forever
↗
January 26, 2026
Via
The Motley Fool
Topics
Intellectual Property
Stability Meets Scale: Why Johnson & Johnson is Poised for a Breakout 2026
January 23, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bankruptcy
Economy
Viking Therapeutics (VKTX) 2026 Deep Dive: Challenging the Obesity Duopoly
January 23, 2026
Via
Finterra
Topics
Intellectual Property
2 High-Yielding Dividend Stocks That Retirees Can Rely on for Recurring Income
↗
January 22, 2026
Via
The Motley Fool
Topics
Stocks
My Top 4 Stocks to Buy in Early 2026
↗
January 22, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
The Titan’s Balance: Johnson & Johnson Reaches Record Highs Amidst Legal Hurdles and Med-Tech Transformation
January 20, 2026
Via
MarketMinute
Topics
Bankruptcy
Lawsuit
World Trade
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 223.43
When was AbbVie last traded?
The last trade of AbbVie was at 02/06/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.